Because of the damning evidence against them, Monsanto has agreed to a $10 billion settlement covering an estimated 95,000 claimants.
The settlement fund only covers medical treatment that occurs up to December 31, 2020, so time is of the essence for claimants that want to participate in this settlement.
Monsanto’s herbicide Roundup first hit the market in 1974.
Since then, hundreds of thousands of individuals have used the product to kill weeds.
Monsanto markets the product as a clean, safe herbicide, even arguing until 1996 that it was safer than table salt, but this is not true.
On the contrary, glyphosate, Roundup’s active ingredient, can cause Non-Hodgkin Lymphoma (NHL), a form of cancer.
Glyphosate was given a designation as a probable cancer-causing agent by the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) in 2015.
Internal documents that came to light during the discovery phase of lawsuits against Monsanto reveal that the company knew of glyphosate’s danger for decades and made substantial efforts to keep this information private.
How Pre-Settlement Funding Can Help
While time is of the essence to file a claim, the settlement will not be paid out immediately.
This is a problem for many victims of Roundup who suffer from NHL. On top of the tremendous pain and suffering that comes with NHL and other forms of cancer, these diseases impede your ability to work and can bring significant medical bills with them.
The devastating financial strain of these costs on a household can compound quickly.
If you’re filing a Roundup cancer lawsuit and need some extra funding to stay afloat financially before receiving a settlement payout, consider a pre-settlement funding agreement through Ally Lawsuit Loans.
Ally Lawsuit Loans can help relieve your immediate financial pressure as you wait for the conclusion of your Monsanto Roundup lawsuit.
To this end, we offer a lowest-rate guarantee, 24-hour application processing, and reassurance that you’ll pay nothing if your case falls short.
Administration of the Roundup Settlement Fund
Epiq Legal Solutions has been appointed as the sole neutral, third-party claims administrator in the Monsanto lawsuits settlement fund.
Epiq will review all claims, determine their eligibility, and determine each claimant’s total award.
Roundup Settlement Fund Point System
To ensure fair, objective application and distribution of settlement funds, the Epiq system for assessing each claimant’s reward will apply a “points scheme.”
The point system will look at several factors in each case and award points to claimants based on those factors.
Some, but not all of the factors that will be used to determine each claimant’s number of points include:
- Age at diagnosis of NHL;
- Type of NHL;
- Extent and nature of treatment for NHL;
- Total amount and duration of Roundup exposure before diagnosis;
- Length of time between initial exposure of Roundup and NHL diagnosis;
- Severity of injury; and
- Existence of other risk factors for developing NHL before NHL diagnosis.
The more strongly these factors apply to you, the higher their point value is.
For example, someone whose diagnosis comes at the age of 30 will have a higher point value in the age category than someone whose diagnosis comes at the age of 60.
The various categories are split into five levels to gauge their severity.
At the highest level (level five) is a claimant who passes away due to their exposure to glyphosate, was otherwise relatively healthy, and was 17 years old at the time of their diagnosis.
On the other hand, at the lowest point value is a claimant who had numerous existing health issues, was 80 years old or older at the time of their diagnosis, and did not receive NHL treatment.
While a claimant can file an appeal against their points award, only one appeal is possible, and the appeal decision is final.
In employing a point system, the Roundup settlement program aims to distribute settlement funds in an objectively verifiable and equitable manner.
Extraordinary Injury Fund (EIF)
Some claimants will qualify for compensation in addition to their basic settlement award.
This extra compensation comes from the settlement’s extraordinary injury fund (EIF).
To be eligible for additional compensation from the EIF, a claimant must suffer from damages that surpass a typical Roundup lawsuit claim.
Some of the circumstances that will bring a claim to the EIF level include the following:
- Medical certification demonstrating claimant has just six months to live;
- Stem cell or CAR-T treatment;
- Three or more cycles of chemotherapy;
- Four nights or more spent in the hospital due to NHL treatment;
- Medical certification demonstrating claimant’s inability to have children due to NHL treatment;
- Economic loss over $200,000;
- Organ damage as a result of NHL treatment;
- An inability to walk without assistance as a result of NHL treatment; and
- Permanent disability as a result of NHL treatment.
These are not the only circumstances that justify additional compensation from the EIF.
Other extenuating circumstances related to NHL treatment or diagnosis that rise above an ordinary level can qualify a claimant for additional funding from the Roundup EIF Settlement Program.
Qualifying for Funding
To qualify for pre-settlement funding of your Monsanto Roundup lawsuit from Ally Lawsuit Loans, a claimant must fulfill three criteria:
- A claimant must have proof of exposure to Roundup;
- A claimant must show a medical diagnosis of NHL; and
- A claimant must enter into the Roundup settlement program and show proof of enrollment.
If you can show each of these criteria, Ally Lawsuit Loans can offer pre-settlement funding to help you make ends meet while waiting for your claim’s payment.
Don’t Let This Opportunity Pass You By
If you suffer from NHL due to Roundup exposure, you deserve compensation.
The settlement fund set up for the Monsanto Roundup cancer lawsuit provides the perfect opportunity to get compensation for your injuries without having to hire an attorney and file your own lawsuit.
However, the fund only covers medical care before December 31, 2020, so don’t let this opportunity pass you by.
Keep in mind that it will take time for Epiq to evaluate your claim and for you to receive your compensation.
To make sure your bills are covered in the meantime, contact Ally Lawsuit Loans today.
Ally Lawsuit Loans has extensive experience providing pre-settlement funding to class-members who are awaiting payment from settlement funds similar to the one set up for claimants in the Monsanto Roundup cancer lawsuit, so we can help you get the most money possible upfront.
With our guarantee of the lowest rate in the industry, a quick 24-hour application turnaround, and our promise that you will not owe us a penny if your case is not successful, you can be confident that Ally Lawsuit Loans will get you the best deal possible.
Life doesn’t wait for your settlement, and you deserve an ally.
Contact Ally Lawsuit Loans today for more information.